http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9810284-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25f5e60cca882cd756ee1cd36c3fef16
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-51
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54326
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56977
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
filingDate 1997-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_161e0bdfc89ea8d1adbe98c676a61c83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e215309c58f0acb016ab58b78007c65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59124811ec5a4a6ccdcde342eb81739e
publicationDate 1998-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9810284-A1
titleOfInvention Purification of antigen-specific t cells
abstract A new method to capture, purify and expand antigen-specific T lymphocites has been developed using magnetic beads coated with recombinant MHC class I molecules. This method was optimized using homogenous populations of naive T cells purified from mice transgenic for the 2C T cell receptor (TCR). These T cells were captured on beads coated with MHC class I molecules and the relevant antigenic peptides. MHC and peptide specificity was confirmed by the usage of irrelevant MHC peptide combinations. An enrichment of 800 to 1600 fold was measured, using 2C T cells mixed with irrelevant T cells, starting from a 2C T cell frequency of 1/3000. The same approach was used to purify antigen-specific CD8+ T cells from total CD8+ T cells from naive mice. The recovered cells could be expanded and specifically kill target cells in vitro; they had a significant effect in vivo as well. We expect this procedure to be suitable to purify and expand in vitro tumor- and virus-specific killer T cells for use in cell therapy.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8835188-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8835187-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10119134-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1873526-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11154833-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1179176-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1385004-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1179176-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002542483-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8088586-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10392614-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11667973-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102017125150-B4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102017125150-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9816088-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4673978-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9977017-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10876107-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9463431-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8865479-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6268411-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9840745-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8609436-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9494575-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114269905-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10590483-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8772049-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11118176-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6448071-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019081642-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6734013-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6458354-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10137426-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8445193-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10294454-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11512288-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2365331-A3
priorityDate 1996-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5045320-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5529921-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850

Total number of triples: 72.